Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study

Jiang HT, Li W, Zhang B, Gong Q, Qie HL

International Journal of General Medicine 2021, 14:7625-7637

Published Date: 2 November 2021